{"disease":{"id":"endometrial-neoplasms","name":"endometrial neoplasms"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-07260437","indication_name":"Advanced or metastatic solid tumors (including ovarian, endometrial, and breast neoplasms)","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07260437","generic_name":"pf-07260437","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Unknown","drug_class":"Unknown oncology compound","quality_score":null,"revenue":null,"mechanism":"Mechanism of action unknown; experimental oncology compound discontinued during Phase 1 development."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03291275","title":"Survival Outcomes of Uterine Malignancies in Chinese Population","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT00341458","title":"Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07298707","title":"Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05634798","title":"An Observational Study Based on Endometrial Cancer Risk Screening Model","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03291106","title":"Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05687084","title":"Uterine Manipulator Versus No Uterine Manipulator in Endometrial Cancer Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1030,"lead_sponsor_name":"Universita di Verona","has_results":false},{"nct_id":"NCT04634877","title":"Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":990,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05588076","title":"Endometrial Lesions Predictions","phase":"","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03884101","title":"Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":842,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03517449","title":"Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":827,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT04269200","title":"Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":805,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03935282","title":"Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":645,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT03778255","title":"Sentinel Lymph Node Mapping In Endometrial Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05007106","title":"MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":613,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05974995","title":"Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":566,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03207061","title":"Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT03543215","title":"Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT03917147","title":"Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination","phase":"","overall_status":"COMPLETED","enrollment_count":435,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT05334303","title":"The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05793749","title":"Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT06126393","title":"MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT04008797","title":"A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":301,"lead_sponsor_name":"Eisai Inc.","has_results":false},{"nct_id":"NCT05977829","title":"Endometrial Malignancy in Breast Cancer Patients With or Without AUB","phase":"","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT05173987","title":"Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":280,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT02690259","title":"Sentinel Lymph Node Detection in Endometrial Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT05194072","title":"A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":250,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT02725268","title":"A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02393248","title":"Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":201,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT05610501","title":"Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06023862","title":"A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05180474","title":"GEN1047 for Solid Tumors - First in Human (FIH) Trial","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":179,"lead_sponsor_name":"Genmab","has_results":false},{"nct_id":"NCT03112733","title":"Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers","phase":"","overall_status":"UNKNOWN","enrollment_count":171,"lead_sponsor_name":"Ilker Kahramanoglu","has_results":false},{"nct_id":"NCT06751329","title":"A Study of DM002 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Xadcera Biopharmaceutical (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT07114653","title":"The Role of POLE Mutation in High Risk Endometrial Cancer.","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT03517488","title":"A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT03207074","title":"Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT05375136","title":"A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Eisai Korea Inc.","has_results":false},{"nct_id":"NCT07038369","title":"A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":134,"lead_sponsor_name":"Atavistik Bio, Inc","has_results":false},{"nct_id":"NCT04865289","title":"Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05657483","title":"Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT03570437","title":"Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"University of Manchester","has_results":false},{"nct_id":"NCT06003231","title":"A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT06714617","title":"Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"SystImmune Inc.","has_results":false},{"nct_id":"NCT04665921","title":"A Study of SGN-STNV in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":111,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT06521684","title":"Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04972682","title":"[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Moscow City Oncology Hospital No. 62","has_results":false},{"nct_id":"NCT04867109","title":"HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT07040657","title":"Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT05191212","title":"Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","has_results":false},{"nct_id":"NCT05316935","title":"GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Xiaojun Chen","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}